Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene

Journal of the American College of Cardiology

Volumn 36, Issue 5, 2000, Pages 1520-1525

  Mrozikiewicz, Przemyslaw M ^a   Cascorbi, Ingolf ^a   Ziemer, Sabine ^a   Laule, Michael ^a   Meisel, Christian ^a   Stangl, Verena ^a   Rutsch, Wolfgang ^a   Wernecke, Klaus ^a   Baumann, Gert ^a   Roots, Ivar ^a   Stangl, Karl ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A;

ADULT; AGED; ALLELE; ARTICLE; ATHERECTOMY; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; GENETIC RISK; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARGININE; ATHERECTOMY, CORONARY; CORONARY DISEASE; FACTOR VII; FEMALE; GLUTAMINE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POINT MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS; STENTS; TIME FACTORS;

EID: 0034332686     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00925-6     Document Type: Article

References (23)

1. The molecular basis of blood coagulation
2. Initiation and regulation of tissue factor-dependent blood coagulation
3. Tissue factor: Then and now
4. Cells and the activation of factor VII
5. Structure of the extracellular domain of human tissue factor: Location of the factor VIIa binding site
6. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction
7. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals
8. Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis
9. 353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies
10. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: A case-controlled study
11. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature
12. 'Optimal' directional coronary atherectomy: Final results of the Optimal Atherectomy Restenosis Study (OARS)
13. A polymorphism in the 5' region of coagulation factor VII gene (F7) caused by an inserted decanucleotide
14. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
15. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates
16. Functional characterization of the human factor VII 5' flanking region
17. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis
18. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
19. Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: The Framingham Heart Study
20. Balloon angioplasty versus new device intervention: Clinical outcomes. A comparison of the NHLBI and NACI registries
21. The decanucleotide insertion/deletion polymorphism in the promoter region of the coagulation factor VII gene and the risk of myocardial infarction
22. 353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study
23. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis